Cargando…
Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study
An association between trimetazidine (TMZ), an anti-anginal drug, and parkinsonism has been reported in a number of studies. However, evidence from studies with long-term follow-up and better validity is lacking. We investigated the risk of TMZ-associated parkinsonism, specifically the incidence rat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579582/ https://www.ncbi.nlm.nih.gov/pubmed/33020406 http://dx.doi.org/10.3390/ijerph17197256 |